S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   99.82 (-0.79%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   95.75 (-0.82%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   297.26 (-2.79%)
S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   99.82 (-0.79%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   95.75 (-0.82%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   297.26 (-2.79%)
S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   99.82 (-0.79%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   95.75 (-0.82%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   297.26 (-2.79%)
S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   99.82 (-0.79%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   95.75 (-0.82%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   297.26 (-2.79%)
NASDAQ:ESTA

Establishment Labs - ESTA Stock Forecast, Price & News

$68.34
-2.11 (-3.00%)
(As of 03/22/2023 03:58 PM ET)
Add
Compare
Today's Range
$67.96
$71.30
50-Day Range
$64.37
$74.47
52-Week Range
$44.03
$93.80
Volume
88,896 shs
Average Volume
120,364 shs
Market Capitalization
$1.67 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$100.86

Establishment Labs MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
42.8% Upside
$100.86 Price Target
Short Interest
Bearish
9.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of Establishment Labs in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$254,184 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.73) to ($1.42) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Medical Sector

730th out of 983 stocks

Surgical Appliances & Supplies Industry

18th out of 23 stocks


ESTA stock logo

About Establishment Labs (NASDAQ:ESTA) Stock

Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.

Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

ESTA Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Establishment Labs Holdings Inc.
See More Headlines
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

ESTA Company Calendar

Last Earnings
2/27/2023
Today
3/22/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ESTA
Fax
N/A
Employees
746
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$100.86
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$65.00
Forecasted Upside/Downside
+43.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-75,210,000.00
Pretax Margin
-45.04%

Debt

Sales & Book Value

Annual Sales
$161.70 million
Book Value
($0.34) per share

Miscellaneous

Free Float
21,393,000
Market Cap
$1.72 billion
Optionable
Not Optionable
Beta
1.03

Key Executives

  • Juan José Chacón QuirósJuan José Chacón Quirós
    Chief Executive Officer & Director
  • Paul D. Rodio
    Chief Operating Officer
  • Raj Denhoy
    Chief Financial Officer
  • Roberto de Mezerville
    Chief Technology Officer
  • S. Ross Mansbach
    Chief Compliance Officer & General Counsel













ESTA Stock - Frequently Asked Questions

Should I buy or sell Establishment Labs stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings
or view top-rated stocks.

What is Establishment Labs' stock price forecast for 2023?

5 brokerages have issued 12-month price targets for Establishment Labs' stock. Their ESTA share price forecasts range from $65.00 to $125.00. On average, they expect the company's stock price to reach $100.86 in the next twelve months. This suggests a possible upside of 43.2% from the stock's current price.
View analysts price targets for ESTA
or view top-rated stocks among Wall Street analysts.

How have ESTA shares performed in 2023?

Establishment Labs' stock was trading at $65.65 at the start of the year. Since then, ESTA shares have increased by 7.3% and is now trading at $70.45.
View the best growth stocks for 2023 here
.

When is Establishment Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our ESTA earnings forecast
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) released its earnings results on Monday, February, 27th. The company reported ($0.55) EPS for the quarter, topping the consensus estimate of ($0.71) by $0.16. The firm earned $43.81 million during the quarter, compared to analysts' expectations of $43.70 million. Establishment Labs had a negative trailing twelve-month return on equity of 422.08% and a negative net margin of 46.51%.

What ETFs hold Establishment Labs' stock?
What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs updated its FY 2023 earnings guidance on Monday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $200.00 million-$210.00 million, compared to the consensus revenue estimate of $205.03 million.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

(ESTA) raised $50 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Brown Advisory Inc. (6.08%), Cowen AND Company LLC (3.52%), Neuberger Berman Group LLC (2.71%), UBS Group AG (1.65%), Morgan Stanley (1.24%) and Artisan Partners Limited Partnership (1.17%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Renee Gaeta and Santos Salvador Dada.
View institutional ownership trends
.

How do I buy shares of Establishment Labs?

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $70.45.

How much money does Establishment Labs make?

Establishment Labs (NASDAQ:ESTA) has a market capitalization of $1.72 billion and generates $161.70 million in revenue each year. The company earns $-75,210,000.00 in net income (profit) each year or ($3.07) on an earnings per share basis.

How many employees does Establishment Labs have?

The company employs 746 workers across the globe.

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The official website for the company is www.establishmentlabs.com. The company can be reached via phone at (062) 434-2400 or via email at ir@establishmentlabs.com.

This page (NASDAQ:ESTA) was last updated on 3/22/2023 by MarketBeat.com Staff